REPLIMUNE GROUP, INC. Other Income and Expense
REPLIMUNE GROUP, INC. (REPL) reported Other Income and Expense of -$1.52 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Other Income
us-gaap:NonoperatingIncomeExpense · last filed 2026-08-14
- REPLIMUNE GROUP, INC. nonoperating income (expense) for the quarter ending 2026-06-30 was -$1.52M, a 140.73% decline year-over-year.
- REPLIMUNE GROUP, INC. nonoperating income (expense) for the quarter ending 2026-03-31 was -$119.00K, a 102.34% decline year-over-year.
- REPLIMUNE GROUP, INC. nonoperating income (expense) for the quarter ending 2025-12-31 was $627.00K, a 146.85% increase year-over-year.
- REPLIMUNE GROUP, INC. nonoperating income (expense) for the quarter ending 2025-09-30 was $1.19M, a 79.68% decline year-over-year.
- REPLIMUNE GROUP, INC. nonoperating income (expense) for fiscal 2026 was $5.43M, a 63.32% decline from fiscal 2025.
- REPLIMUNE GROUP, INC. nonoperating income (expense) for fiscal 2025 was $14.80M, a 23.67% decline from fiscal 2024.
- REPLIMUNE GROUP, INC. nonoperating income (expense) for fiscal 2024 was $19.39M, a 528.63% increase from fiscal 2023.
- REPLIMUNE GROUP, INC. nonoperating income (expense) for fiscal 2023 was $3.08M, a 1009.35% increase from fiscal 2022.
| Period end | Nonoperating Income (Expense) 3 month | Nonoperating Income (Expense) 6 month | Nonoperating Income (Expense) 9 month | Nonoperating Income (Expense) 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.52M 10-Q · filed 2026-08-14 | -$1.64M derived: sum of 2 quarters · filed 2026-08-14 | -$1.01M derived: sum of 3 quarters · filed 2026-08-14 | $180.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | -$119.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-29 | $508.00K derived: sum of 2 quarters · filed 2026-06-29 | $1.70M derived: sum of 3 quarters · filed 2026-06-29 | $5.43M 10-K · filed 2026-06-29 |
| 2025-12-31 | $627.00K 10-Q · filed 2026-02-03 | $1.82M derived: sum of 2 quarters · filed 2026-02-03 | $5.55M 10-Q · filed 2026-02-03 | $10.64M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-09-30 | $1.19M 10-Q · filed 2025-11-06 | $4.92M 10-Q · filed 2025-11-06 | $10.01M derived: sum of 3 quarters · filed 2026-08-14 | $10.27M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $3.73M 10-Q · filed 2026-08-14 | $8.82M derived: sum of 2 quarters · filed 2026-08-14 | $9.07M derived: sum of 3 quarters · filed 2026-08-14 | $14.94M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $5.09M derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-29 | $5.34M derived: sum of 2 quarters · filed 2026-06-29 | $11.21M derived: sum of 3 quarters · filed 2026-06-29 | $14.80M 10-K · filed 2026-06-29 |
| 2024-12-31 | $254.00K 10-Q · filed 2026-02-03 | $6.12M derived: sum of 2 quarters · filed 2026-02-03 | $9.71M 10-Q · filed 2026-02-03 | $13.33M derived: sum of 4 quarters · filed 2026-02-03 |
| 2024-09-30 | $5.86M 10-Q · filed 2025-11-06 | $9.46M 10-Q · filed 2025-11-06 | $13.07M derived: sum of 3 quarters · filed 2025-11-06 | $18.96M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $3.60M 10-Q · filed 2025-08-07 | $7.21M derived: sum of 2 quarters · filed 2025-08-07 | $13.10M derived: sum of 3 quarters · filed 2025-08-07 | $16.69M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $3.62M derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-22 | $9.51M derived: sum of 2 quarters · filed 2025-05-22 | $13.10M derived: sum of 3 quarters · filed 2025-05-22 | $19.39M 10-K · filed 2025-05-22 |
| 2023-12-31 | $5.89M 10-Q · filed 2025-02-12 | $9.48M derived: sum of 2 quarters · filed 2025-02-12 | $15.77M 10-Q · filed 2025-02-12 | $19.82M derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-09-30 | $3.59M 10-Q · filed 2024-11-12 | $9.88M 10-Q · filed 2024-11-12 | $13.92M derived: sum of 3 quarters · filed 2024-11-12 | $15.86M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $6.29M 10-Q · filed 2024-08-08 | $10.34M derived: sum of 2 quarters · filed 2024-08-08 | $12.28M derived: sum of 3 quarters · filed 2024-08-08 | $10.76M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $4.04M derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-16 | $5.98M derived: sum of 2 quarters · filed 2024-05-16 | $4.46M derived: sum of 3 quarters · filed 2024-05-16 | $3.08M 10-K · filed 2024-05-16 |
| 2022-12-31 | $1.94M 10-Q · filed 2024-02-08 | $417.00K derived: sum of 2 quarters · filed 2024-02-08 | -$960.00K 10-Q · filed 2024-02-08 | -$668.00K derived: sum of 4 quarters · filed 2024-02-08 |
| 2022-09-30 | -$1.52M 10-Q · filed 2023-11-07 | -$2.90M 10-Q · filed 2023-11-07 | -$2.61M derived: sum of 3 quarters · filed 2023-11-07 | -$2.58M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | -$1.38M 10-Q · filed 2023-08-03 | -$1.08M derived: sum of 2 quarters · filed 2023-08-03 | -$1.06M derived: sum of 3 quarters · filed 2023-08-03 | -$1.17M derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | $292.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-05-18 | $316.00K derived: sum of 2 quarters · filed 2023-05-18 | $208.00K derived: sum of 3 quarters · filed 2023-05-18 | $278.00K 10-K · filed 2023-05-18 |
| 2021-12-31 | $24.00K 10-Q · filed 2023-02-09 | -$84.00K derived: sum of 2 quarters · filed 2023-02-09 | -$14.00K 10-Q · filed 2023-02-09 | $671.00K derived: sum of 4 quarters · filed 2023-02-09 |
| 2021-09-30 | -$108.00K 10-Q · filed 2022-11-03 | -$38.00K 10-Q · filed 2022-11-03 | $647.00K derived: sum of 3 quarters · filed 2022-11-03 | -$861.00K derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | $70.00K 10-Q · filed 2022-08-04 | $755.00K derived: sum of 2 quarters · filed 2022-08-04 | -$753.00K derived: sum of 3 quarters · filed 2022-08-04 | -$1.19M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $685.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-19 | -$823.00K derived: sum of 2 quarters · filed 2022-05-19 | -$1.25M derived: sum of 3 quarters · filed 2022-05-19 | -$915.00K 10-K · filed 2022-05-19 |
| 2020-12-31 | -$1.51M 10-Q · filed 2022-02-03 | -$1.94M derived: sum of 2 quarters · filed 2022-02-03 | -$1.60M 10-Q · filed 2022-02-03 | -$1.00M derived: sum of 4 quarters · filed 2022-02-03 |
| 2020-09-30 | -$432.00K 10-Q · filed 2021-11-04 | -$92.00K 10-Q · filed 2021-11-04 | $504.00K derived: sum of 3 quarters · filed 2021-11-04 | $979.00K derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | $340.00K 10-Q · filed 2021-08-06 | $936.00K derived: sum of 2 quarters · filed 2021-08-06 | $1.41M derived: sum of 3 quarters · filed 2021-08-06 | $2.51M derived: sum of 4 quarters · filed 2021-08-06 |
| 2020-03-31 | $596.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-05-20 | $1.07M derived: sum of 2 quarters · filed 2021-05-20 | $2.17M derived: sum of 3 quarters · filed 2021-05-20 | $3.57M 10-K · filed 2021-05-20 |
| 2019-12-31 | $475.00K 10-Q · filed 2021-02-04 | $1.58M derived: sum of 2 quarters · filed 2021-02-04 | $2.98M 10-Q · filed 2021-02-04 | $4.15M derived: sum of 4 quarters · filed 2021-02-04 |
| 2019-09-30 | $1.10M 10-Q · filed 2020-11-05 | $2.50M 10-Q · filed 2020-11-05 | $3.67M derived: sum of 3 quarters · filed 2020-11-05 | $6.14M derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | $1.40M 10-Q · filed 2020-08-07 | $2.57M derived: sum of 2 quarters · filed 2020-08-07 | $5.03M derived: sum of 3 quarters · filed 2020-08-07 | $5.68M derived: sum of 4 quarters · filed 2020-08-07 |
| 2019-03-31 | $1.17M derived: 10-K 12 month − 10-Q 9 month · filed 2020-06-03 | $3.63M derived: sum of 2 quarters · filed 2020-06-03 | $4.28M derived: sum of 3 quarters · filed 2020-06-03 | $112.00K 10-K · filed 2020-06-03 |
| 2018-12-31 | $2.46M 10-Q · filed 2020-02-13 | $3.11M derived: sum of 2 quarters · filed 2020-02-13 | -$1.06M 10-Q · filed 2020-02-13 | -$841.00K derived: sum of 4 quarters · filed 2020-06-03 |
| 2018-09-30 | $643.00K 10-Q · filed 2019-11-12 | -$3.52M 10-Q · filed 2019-11-12 | -$3.31M derived: sum of 3 quarters · filed 2020-06-03 | -$2.93M derived: sum of 4 quarters · filed 2020-06-03 |
| 2018-06-30 | -$4.17M 10-Q · filed 2019-08-14 | -$3.95M derived: sum of 2 quarters · filed 2020-06-03 | -$3.57M derived: sum of 3 quarters · filed 2020-06-03 | -$3.97M derived: sum of 4 quarters · filed 2020-06-03 |
| 2018-03-31 | $217.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-06-03 | $595.00K derived: sum of 2 quarters · filed 2020-06-03 | $191.00K derived: sum of 3 quarters · filed 2020-06-03 | -$473.00K 10-K · filed 2020-06-03 |
| 2017-12-31 | $378.00K 10-Q · filed 2019-02-14 | -$26.00K derived: sum of 2 quarters · filed 2019-02-14 | -$690.00K 10-Q · filed 2019-02-14 | |
| 2017-09-30 | -$404.00K 10-Q · filed 2018-11-14 | -$780.00K 10-Q · filed 2018-11-14 | ||
| 2017-06-30 | -$376.00K 10-Q · filed 2018-08-30 | |||
| 2017-03-31 | $1.94M 10-K · filed 2019-06-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B |